Literature DB >> 15749164

Functional MRI using molecular imaging agents.

Alan Jasanoff1.   

Abstract

Contrast agents for magnetic resonance imaging (MRI) have recently been used as cellular-level probes of neural function. New in vivo labeling strategies now enable researchers to follow plasticity of brain activation patterns and cellular structure over time. On the horizon is the prospect that molecular imaging agents specifically designed for functional imaging (fMRI) on a relatively fast timescale could offer an alternative to conventional hemodynamics-based approaches. Development of several MRI sensors has defined principles by which imaging agents for "molecular fMRI" can be constructed; application of engineered sensors for cellular-level correlates of neuronal activity would allow researchers to combine the noninvasiveness of MRI with spatial resolution of tens of microns and temporal resolution of 100ms or less. Facilitated by advances in imaging-agent delivery methods and model systems appropriate for high-resolution neuroimaging, novel molecular imaging strategies continue to potentiate MRI as a tool for mechanistic investigation of neural systems.

Mesh:

Substances:

Year:  2005        PMID: 15749164     DOI: 10.1016/j.tins.2004.12.007

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  10 in total

Review 1.  Molecular imaging of brain tumors: a bridge between clinical and molecular medicine?

Authors:  B J Schaller; M Modo; M Buchfelder
Journal:  Mol Imaging Biol       Date:  2007 Mar-Apr       Impact factor: 3.488

Review 2.  MRI contrast agents for functional molecular imaging of brain activity.

Authors:  Alan Jasanoff
Journal:  Curr Opin Neurobiol       Date:  2007-10       Impact factor: 6.627

3.  Fractionated manganese-enhanced MRI.

Authors:  Nicholas A Bock; Fernando F Paiva; Afonso C Silva
Journal:  NMR Biomed       Date:  2008-06       Impact factor: 4.044

4.  Brain active transmembrane water cycling measured by MR is associated with neuronal activity.

Authors:  Ruiliang Bai; Charles S Springer; Dietmar Plenz; Peter J Basser
Journal:  Magn Reson Med       Date:  2018-09-08       Impact factor: 4.668

Review 5.  Current molecular imaging of spinal tumors in clinical practice.

Authors:  Nora Sandu; Gabriele Pöpperl; Marie-Elisabeth Toubert; Toma Spiriev; Belachew Arasho; Mikael Orabi; Bernhard Schaller
Journal:  Mol Med       Date:  2011-01-03       Impact factor: 6.354

6.  Calcium-sensitive MRI contrast agents based on superparamagnetic iron oxide nanoparticles and calmodulin.

Authors:  Tatjana Atanasijevic; Maxim Shusteff; Peter Fam; Alan Jasanoff
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-26       Impact factor: 11.205

7.  Water-soluble porphyrins as a dual-function molecular imaging platform for MRI and fluorescence zinc sensing.

Authors:  Xiao-An Zhang; Katherine S Lovejoy; Alan Jasanoff; Stephen J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

8.  Brain circuits activated by female sexual behavior evaluated by manganese enhanced magnetic resonance imaging.

Authors:  Alejandro Aguilar-Moreno; Juan Ortiz; Luis Concha; Sarael Alcauter; Raúl G Paredes
Journal:  PLoS One       Date:  2022-08-01       Impact factor: 3.752

Review 9.  Molecular fMRI.

Authors:  Benjamin B Bartelle; Ali Barandov; Alan Jasanoff
Journal:  J Neurosci       Date:  2016-04-13       Impact factor: 6.167

10.  Neuron labeling with rhodamine-conjugated Gd-based MRI contrast agents delivered to the brain via focused ultrasound.

Authors:  Sophie V Morse; Tamara Boltersdorf; Bethany I Harriss; Tiffany G Chan; Nicoleta Baxan; Hee Seok Jung; Antonios N Pouliopoulos; James J Choi; Nicholas J Long
Journal:  Theranostics       Date:  2020-02-03       Impact factor: 11.556

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.